UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SAT0131 The role of ultrasound for the assessment of patients with active rheumatoid arthritis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.927

2018

Volltextzugriff (PDF)

AB0221 The use of ultrasound to identify disease activity in patients with rheumatoid arthritis in clinical remission or low disease activity in a real-life setting

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1294

2018

Volltextzugriff (PDF)

AB1209 Usefulness of imagenology to differential diagnosis in patients with presumed seronegative rheumatoid arthritis and other arthropathies

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1703

2018

Volltextzugriff (PDF)

SAT0242 Effectiveness of conventional dmard therapy in patients with rheumatoid arthritis treated under a treat to target model – lessons from a real-life cohort

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.982

2018

Volltextzugriff (PDF)

AB0903 Preliminary Data From Osteoporosis Study in Lung Transplantation Patients in Vall D'hebron Hospital

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1202-1202

2015

Volltextzugriff (PDF)

AB0309 Analysis of the Correlation Between Das 28 Index and its Ultrasonographic Equivalent (ECODAS)

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.997-997

2015

Volltextzugriff (PDF)

AB0707 Arthritis prevalence and biological markers in primary sjÖgren’s syndrome

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.679-679

2013

Volltextzugriff (PDF)

AB0487 UTILITY OF HEMATOLOGICAL INFLAMMATORY INDEXES IN DISEASE SEVERITY MEASUREMENT OF PSORIASIS AND PSORIATIC ARTHRITIS PATIENTS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1510-1511

2024

Volltextzugriff (PDF)

AB1180 CLINICAL UTILITY OF NAILFOLD CAPILLAROSCOPY: DESCRIPTION OF A REAL-LIFE COHORT

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1925-1926

2024

Volltextzugriff (PDF)

AB0419 ULTRASOUND FINDINGS IN PSORIATIC ARTHRITIS ASSOCIATED WITH CLINICAL AND RADIOLOGICAL OUTCOMES

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1461-1461

2024

Volltextzugriff (PDF)

AB0231 PROLIFERATIVE SYNOVITIS: AN ULTRASOUND PATTERN ASSOCIATED WITH EROSIVE DISEASE AND CHRONIC USE OF GLUCOCORTICOIDS IN PATIENTS WITH ARTHRITIS. A CROSS-SECTIONAL AND MULTICENTER STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1354-1355

2024

Volltextzugriff (PDF)

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.643-649

2017

Volltextzugriff (PDF)

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0

Annals of the rheumatic diseases, 2012-03, Vol.71 (3), p.382-385

2012

Volltextzugriff (PDF)

POS0480 ULTRASOUND SYNOVITIS AND NEUTROPHILIC ACTIVITY MARKERS (PLASMA CALPROTECTIN AND NEUTROPHIL EXTRACELLULAR TRAPS) IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGICAL OR JAK INHIBITORS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.500-501

2023

Volltextzugriff (PDF)

AB0317 PLASMA NETS LEVELS IN ESTABLISHED RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGICAL OR JAK INHIBITOR THERAPY AND ASSOCIATION WITH DISEASE ACTIVITY

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1342-1343

2023

Volltextzugriff (PDF)

POS0452 DIAGNOSTIC AND PROGNOSTIC ROLE OF SERUM KL-6 IN RHEUMATOID ARTHRITIS‑ASSOCIATED INTERSTITIAL LUNG DISEASE

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.482-483

2023

Volltextzugriff (PDF)

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry

Rheumatology (Oxford, England), 2011-11, Vol.50 (11), p.1999-2004

2011

Volltextzugriff (PDF)

Ohio’s Medicaid Expansion and Unmet Health Needs Among Low-Income Women of Reproductive Age

Maternal and child health journal, 2018-12, Vol.22 (12), p.1771-1779

2018

Volltextzugriff (PDF)

322 Long-term benefits of early ivacaftor initiation in people with cystic fibrosis

Journal of cystic fibrosis, 2024-09, Vol.23, p.S170-S171

2024

Volltextzugriff (PDF)

WS08.04 Real-world data demonstrate clinical response in people with cystic fibrosis (pwCF) who have select residual function (RF) mutations and are treated with ivacaftor (IVA)

Journal of cystic fibrosis, 2022-06, Vol.21, p.S16

2022

Volltextzugriff (PDF)

Registry-based study in people with cystic fibrosis and an R117H variant treated with ivacaftor

BMJ open respiratory research, 2023-05, Vol.10 (1), p.e001447

2023

Volltextzugriff (PDF)

Measuring hospital‐specific disparities by dual eligibility and race to reduce health inequities

Health services research, 2019-02, Vol.54 (1), p.243-254

2019

Volltextzugriff (PDF)

Axial Disease in Psoriatic Arthritis: A Challenging Domain in Clinical Practice

Diagnostics (Basel), 2024-08, Vol.14 (15), p.1637

2024

Volltextzugriff (PDF)

Provider-Delivered Tobacco Dependence Treatment to Medicaid Smokers

Nicotine & tobacco research, 2014-06, Vol.16 (6), p.786-793

2014

Volltextzugriff (PDF)

Analysis of the correlation between disease activity score 28 and its ultrasonographic equivalent in rheumatoid arthritis patients

European journal of rheumatology, 2020-07, Vol.7 (3), p.118-123

2020

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(32)
Dissertationen
(1)

Sprache

Englisch
(32)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

SAT0131 The role of ultrasound for the assessment of patients with active rheumatoid arthritis

AB0221 The use of ultrasound to identify disease activity in patients with rheumatoid arthritis in clinical remission or low disease activity in a real-life setting

AB1209 Usefulness of imagenology to differential diagnosis in patients with presumed seronegative rheumatoid arthritis and other arthropathies

SAT0242 Effectiveness of conventional dmard therapy in patients with rheumatoid arthritis treated under a treat to target model – lessons from a real-life cohort

AB0903 Preliminary Data From Osteoporosis Study in Lung Transplantation Patients in Vall D'hebron Hospital

AB0309 Analysis of the Correlation Between Das 28 Index and its Ultrasonographic Equivalent (ECODAS)

AB0707 Arthritis prevalence and biological markers in primary sjÖgren’s syndrome

AB0487 UTILITY OF HEMATOLOGICAL INFLAMMATORY INDEXES IN DISEASE SEVERITY MEASUREMENT OF PSORIASIS AND PSORIATIC ARTHRITIS PATIENTS

AB1180 CLINICAL UTILITY OF NAILFOLD CAPILLAROSCOPY: DESCRIPTION OF A REAL-LIFE COHORT

AB0419 ULTRASOUND FINDINGS IN PSORIATIC ARTHRITIS ASSOCIATED WITH CLINICAL AND RADIOLOGICAL OUTCOMES

AB0231 PROLIFERATIVE SYNOVITIS: AN ULTRASOUND PATTERN ASSOCIATED WITH EROSIVE DISEASE AND CHRONIC USE OF GLUCOCORTICOIDS IN PATIENTS WITH ARTHRITIS. A CROSS-SECTIONAL AND MULTICENTER STUDY

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0

POS0480 ULTRASOUND SYNOVITIS AND NEUTROPHILIC ACTIVITY MARKERS (PLASMA CALPROTECTIN AND NEUTROPHIL EXTRACELLULAR TRAPS) IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGICAL OR JAK INHIBITORS

AB0317 PLASMA NETS LEVELS IN ESTABLISHED RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGICAL OR JAK INHIBITOR THERAPY AND ASSOCIATION WITH DISEASE ACTIVITY

POS0452 DIAGNOSTIC AND PROGNOSTIC ROLE OF SERUM KL-6 IN RHEUMATOID ARTHRITIS‑ASSOCIATED INTERSTITIAL LUNG DISEASE

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry

Ohio’s Medicaid Expansion and Unmet Health Needs Among Low-Income Women of Reproductive Age

322 Long-term benefits of early ivacaftor initiation in people with cystic fibrosis

WS08.04 Real-world data demonstrate clinical response in people with cystic fibrosis (pwCF) who have select residual function (RF) mutations and are treated with ivacaftor (IVA)

Registry-based study in people with cystic fibrosis and an R117H variant treated with ivacaftor

Measuring hospital‐specific disparities by dual eligibility and race to reduce health inequities

Axial Disease in Psoriatic Arthritis: A Challenging Domain in Clinical Practice

Provider-Delivered Tobacco Dependence Treatment to Medicaid Smokers

Analysis of the correlation between disease activity score 28 and its ultrasonographic equivalent in rheumatoid arthritis patients

Suchergebnisse filtern